Relationship of proximal tubular injury to chronic kidney disease as assessed by urinary kidney injury molecule-1 in five cohort studies.

BACKGROUND The primary biomarkers used to define CKD are serum creatinine and albuminuria. These biomarkers have directed focus on the filtration and barrier functions of the kidney glomerulus even though albuminuria results from tubule dysfunction as well. Given that proximal tubules make up ∼90% of kidney cortical mass, we evaluated whether a sensitive and specific marker of proximal tubule injury, urinary kidney injury molecule-1 (KIM-1), is elevated in individuals with CKD or with risk factors for CKD. METHODS We measured urinary KIM-1 in participants of five cohort studies from the USA and Sweden. Participants had a wide range of kidney function and were racially and ethnically diverse. Multivariable linear regression models were used to test the association of urinary KIM-1 with demographic, clinical and laboratory values. RESULTS In pooled, multivariable-adjusted analyses, log-transformed, creatinine-normalized urinary KIM-1 levels were higher in those with lower eGFR {β = -0.03 per 10 mL/min/1.73 m(2) [95% confidence interval (CI) -0.05 to -0.02]} and greater albuminuria [β = 0.16 per unit of log albumin:creatinine ratio (95% CI 0.15-0.17)]. Urinary KIM-1 levels were higher in current smokers, lower in blacks than nonblacks and lower in users versus nonusers of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. CONCLUSION Proximal tubule injury appears to be an integral and measurable element of multiple stages of CKD.

[1]  J. Bonventre,et al.  Mammalian Target of Rapamycin Mediates Kidney Injury Molecule 1-Dependent Tubule Injury in a Surrogate Model. , 2016, Journal of the American Society of Nephrology : JASN.

[2]  A. Go,et al.  Chronic Renal Insufficiency Cohort Study (CRIC): Overview and Summary of Selected Findings. , 2015, Clinical journal of the American Society of Nephrology : CJASN.

[3]  R. Vasan,et al.  Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study. , 2015, Clinical journal of the American Society of Nephrology : CJASN.

[4]  J. Bonventre,et al.  KIM‐1‐/TIM‐1‐mediated phagocytosis links ATG5‐/ULK1‐dependent clearance of apoptotic cells to antigen presentation , 2015, The EMBO journal.

[5]  R. Vasan,et al.  Cross-Disciplinary Biomarkers Research: Lessons Learned by the CKD Biomarkers Consortium. , 2015, Clinical journal of the American Society of Nephrology : CJASN.

[6]  L. Hsiao,et al.  KIM-1-mediated phagocytosis reduces acute injury to the kidney. , 2015, Journal of Clinical Investigation.

[7]  D. Gordin,et al.  Kidney Injury Molecule-1 and the Loss of Kidney Function in Diabetic Nephropathy: A Likely Causal Link in Patients With Type 1 Diabetes , 2015, Diabetes Care.

[8]  W. Goessling,et al.  Sequencing of LRP2 reveals multiple rare variants associated with urinary trefoil factor-3. , 2014, Journal of the American Society of Nephrology : JASN.

[9]  P. Houillier,et al.  Decrease in Urinary Creatinine Excretion in Early Stage Chronic Kidney Disease , 2014, PloS one.

[10]  P. Kimmel,et al.  Acute kidney injury and chronic kidney disease as interconnected syndromes. , 2014, The New England journal of medicine.

[11]  S. Kritchevsky,et al.  Urinary kidney injury molecule 1 (KIM-1) and interleukin 18 (IL-18) as risk markers for heart failure in older adults: the Health, Aging, and Body Composition (Health ABC) Study. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  A. Newman,et al.  Association of urinary injury biomarkers with mortality and cardiovascular events. , 2014, Journal of the American Society of Nephrology : JASN.

[13]  P. Kimmel,et al.  Urine stability studies for novel biomarkers of acute kidney injury. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  M. Pirmohamed,et al.  Reference intervals for urinary renal injury biomarkers KIM-1 and NGAL in healthy children. , 2014, Biomarkers in Medicine.

[15]  L. Lind,et al.  Kidney injury molecule (KIM)-1 is associated with insulin resistance: results from two community-based studies of elderly individuals. , 2014, Diabetes research and clinical practice.

[16]  R. Vasan,et al.  Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus , 2014, Diabetologia.

[17]  J. Bonventre,et al.  Urinary expression of novel tissue markers of kidney injury after ureteroscopy, shockwave lithotripsy, and in normal healthy controls. , 2013, Journal of endourology.

[18]  A. McMahon,et al.  Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis. , 2013, The Journal of clinical investigation.

[19]  C. Faes,et al.  Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue? , 2013, Clinical chemistry and laboratory medicine.

[20]  E. Ingelsson,et al.  Urinary kidney injury molecule 1 and incidence of heart failure in elderly men , 2013, European journal of heart failure.

[21]  R. Hanson,et al.  Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes , 2013, Diabetes.

[22]  D. Siscovick,et al.  Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA). , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  M. Joffe,et al.  Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  M. Wagner,et al.  Multiple factors influence glomerular albumin permeability in rats. , 2012, Journal of the American Society of Nephrology : JASN.

[25]  Vanesa Bijol,et al.  Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis , 2012, Kidney international.

[26]  Q. Wang,et al.  Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study , 2012, Endocrine.

[27]  H. Feldman,et al.  Measured GFR does not outperform estimated GFR in predicting CKD-related complications. , 2011, Journal of the American Society of Nephrology : JASN.

[28]  Min Chen,et al.  Urinary kidney injury molecule-1 in patients with IgA nephropathy is closely associated with disease severity. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[29]  S. Bakker,et al.  Glomerular and Tubular Damage Markers Are Elevated in Patients With Diabetes , 2011, Diabetes Care.

[30]  J. Bonventre,et al.  Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase. , 2011, Kidney international.

[31]  Sushrut S Waikar,et al.  Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate. , 2010, Kidney international.

[32]  R. Colvin,et al.  Tubular expression of KIM-1 does not predict delayed function after transplantation. , 2010, Journal of the American Society of Nephrology : JASN.

[33]  B. Astor,et al.  Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[35]  N. Perico,et al.  Kidney injury molecule 1: in search of biomarkers of chronic tubulointerstitial damage and disease progression. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  G. Navis,et al.  Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[37]  S. Waikar,et al.  Urinary biomarkers in the early diagnosis of acute kidney injury. , 2008, Kidney international.

[38]  M. C. V. D. Heuvel,et al.  Tubular kidney injury molecule‐1 (KIM‐1) in human renal disease , 2007, The Journal of pathology.

[39]  B. Molitoris,et al.  The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: retrieval is disrupted in nephrotic states. , 2007, Kidney international.

[40]  J. Coresh,et al.  Association of Cigarette Smoking with Albuminuria in the United States: The Third National Health and Nutrition Examination Survey , 2007, Renal failure.

[41]  S. Bakker,et al.  Tubular kidney injury molecule-1 in protein-overload nephropathy. , 2006, American journal of physiology. Renal physiology.

[42]  M. Loda,et al.  Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma. , 2005, Journal of the American Society of Nephrology : JASN.

[43]  J. Bonventre,et al.  Kidney Injury Molecule-1 ( Kim-1 ) : A Tissue and Urinary Biomarker for Nephrotoxicant-Induced Renal Injury . , 2003 .

[44]  L. Hansson,et al.  Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L , 2004, Scandinavian journal of clinical and laboratory investigation.

[45]  S. Orth Effects of smoking on systemic and intrarenal hemodynamics: influence on renal function. , 2004, Journal of the American Society of Nephrology : JASN.

[46]  E. Vittinghoff,et al.  Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. , 2003, Journal of the American Society of Nephrology : JASN.

[47]  K. Park,et al.  Systemic microvascular leak in an in vivo rat model of ventilator-induced lung injury. , 2003, American journal of respiratory and critical care medicine.

[48]  E. Schulze-Lohoff,et al.  Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome. , 2003, Kidney international.

[49]  S. Somlo,et al.  Kidney injury molecule-1 expression in murine polycystic kidney disease. , 2002, American journal of physiology. Renal physiology.

[50]  M. Gekle,et al.  Albumin Induces NF-κB Expression in Human Proximal Tubule-Derived Cells (IHKE-1) , 2002, Cellular Physiology and Biochemistry.

[51]  J. Bonventre,et al.  Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. , 2002, Kidney international.

[52]  F. Thaiss,et al.  Angiotensin II activates nuclear transcription factor-κB through AT1 and AT2 receptors11See Editorial by Luft, p. 2272. , 2002 .

[53]  F. Thaiss,et al.  Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors. , 2002, Kidney international.

[54]  E. Minetti,et al.  Acute and long-term effects of ACE inhibition on renal haemodynamics in glomerular and interstitial nephropathies , 2002, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[55]  B. Brenner,et al.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.

[56]  E. Ritz,et al.  Acute effects of cigarette smoking on renal hemodynamics. , 2000, Contributions to nephrology.

[57]  G. D'Amico,et al.  Tubulointerstitium as Predictor of Progression of Glomerular Diseases , 1999, Nephron.

[58]  Ji-Hyun Kim,et al.  Spurious correlation between ratios with a common divisor , 1999 .

[59]  Giuseppe Remuzzi,et al.  Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria , 1999, The Lancet.

[60]  Joseph V. Bonventre,et al.  Kidney Injury Molecule-1 (KIM-1), a Putative Epithelial Cell Adhesion Molecule Containing a Novel Immunoglobulin Domain, Is Up-regulated in Renal Cells after Injury* , 1998, The Journal of Biological Chemistry.

[61]  Y. Wang,et al.  Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. , 1997, Journal of the American Society of Nephrology : JASN.

[62]  F. Thaiss,et al.  Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor. , 1997, The Journal of clinical investigation.

[63]  J. Breyer,et al.  Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators. , 1997, Kidney international.

[64]  G. Beck,et al.  Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. , 1996, The New England journal of medicine.

[65]  F. Locatelli,et al.  Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency , 1996 .

[66]  F. Locatelli,et al.  Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. , 1996, The New England journal of medicine.

[67]  G. Remuzzi,et al.  Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[68]  G. Beck,et al.  Progression of overt nephropathy in non-insulin-dependent diabetes. , 1995, Kidney international.

[69]  A Fournier,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1994, The New England journal of medicine.

[70]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.

[71]  H. Endou,et al.  Intrarenal handling of proteins in rats using fractional micropuncture technique. , 1992, The American journal of physiology.

[72]  Aric Invest The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators , 1989 .

[73]  A. Folsom,et al.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.

[74]  S. Rostand,et al.  Racial differences in the incidence of treatment for end-stage renal disease. , 1982, The New England journal of medicine.